NETSTREIT (NYSE:NTST) Price Target Cut to $20.00 by Analysts at Mizuho

NETSTREIT (NYSE:NTST) had its target price lowered by equities researchers at Mizuho from $23.00 to $20.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s price objective points to a potential upside of 10.64% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. BTIG Research raised their price target on NETSTREIT from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, June 26th. Cantor Fitzgerald increased their price objective on shares of NETSTREIT from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Tuesday, July 28th. Stifel Nicolaus boosted their target price on shares of NETSTREIT from $22.25 to $23.50 and gave the stock a “buy” rating in a research report on Thursday, July 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of NETSTREIT in a research note on Friday, August 7th. Finally, Wells Fargo & Company raised their price target on shares of NETSTREIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Thirteen research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, NETSTREIT currently has a consensus rating of “Moderate Buy” and an average target price of $22.96.

NETSTREIT Trading Down 1.0%

Shares of NYSE:NTST opened at $18.08 on Thursday. The company has a market capitalization of $1.84 billion, a PE ratio of 122.07, a P/E/G ratio of 2.50 and a beta of 0.80. The company has a current ratio of 3.55, a quick ratio of 3.54 and a debt-to-equity ratio of 0.88. NETSTREIT has a 12-month low of $17.02 and a 12-month high of $22.47. The business’s fifty day simple moving average is $20.82 and its 200-day simple moving average is $20.45.

NETSTREIT (NYSE:NTST) last posted its earnings results on Wednesday, July 22nd. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.02). NETSTREIT had a net margin of 6.35% and a return on equity of 0.95%. The firm had revenue of $61.28 million for the quarter, compared to analysts’ expectations of $56.41 million. NETSTREIT has set its FY 2026 guidance at 1.370-1.390 EPS. As a group, equities research analysts predict that NETSTREIT will post 1.3 earnings per share for the current fiscal year.

Institutional Investors Weigh In On NETSTREIT

Several hedge funds have recently bought and sold shares of NTST. BlackRock Inc. purchased a new position in shares of NETSTREIT during the 2nd quarter valued at approximately $404,780,000. Principal Financial Group Inc. boosted its holdings in NETSTREIT by 3.4% during the first quarter. Principal Financial Group Inc. now owns 9,535,801 shares of the company’s stock worth $179,560,000 after buying an additional 309,453 shares in the last quarter. Centersquare Investment Management LLC grew its position in NETSTREIT by 3.4% during the fourth quarter. Centersquare Investment Management LLC now owns 3,653,585 shares of the company’s stock valued at $64,449,000 after buying an additional 120,170 shares during the period. Bank of America Corp DE grew its position in NETSTREIT by 12.2% during the first quarter. Bank of America Corp DE now owns 3,433,461 shares of the company’s stock valued at $64,652,000 after buying an additional 372,337 shares during the period. Finally, Deutsche Bank AG purchased a new position in NETSTREIT in the second quarter valued at $44,589,000.

NETSTREIT Company Profile

NETSTREIT Corp. is a real estate investment trust (REIT) focused on owning and managing healthcare real estate in the United States. The company primarily invests in outpatient medical office properties that support essential healthcare services, including clinics, physician practices, specialty care facilities and other medical providers.

NETSTREIT generally leases its properties to healthcare systems, physician groups and other medical operators under long-term, net lease arrangements.